Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to ...

The Federal Reserve rate cuts have sent the market up, but some stocks are rising more than others. That includes small pharmaceutical companies like Wave Life Sciences (NASDAQ: WVE), whose shares ...

Clinical-stage biotechnology company Wave Life Sciences (NASDAQ:WVE) priced an underwritten public offering of ~23.13M of its ordinary shares at a price to the public of $8.00 per ordinary share.

Eager to not meet a similar fate, the National Academy of Sciences has called for planetary defense to be a national priority ...

Truist Financial analyst Joon Lee maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report) yesterday and set a price ...

Truist Financial analyst Joon Lee maintained a Buy rating on Argenx Se (ARGX – Research Report) today. The company’s shares closed ...

A new speaker series brings leading professionals in statistics and data science together with Yale students to talk about career development for women.

Chinese president Xi Jinping yesterday vowed to unleash fresh stimulus just days after the central bank launched its biggest ...

ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today announced that the first patient ...

Hard times are expected to continue for another six to 12 months as the industry works through a backlog of supply.

The biotech sector was in focus last week, with regular pipeline and regulatory updates. Drug approvals were in the spotlight as well. Here's a recap of the week’s most important stories: Biogen BIIB ...

Coronado Research announced today that Gail Kniveton has been appointed as Chief Talent Officer. She brings extensive experience in building teams across the life sciences sector. Working with ...